October 2015 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for October 2015. This roundup includes the latest...
Ranolazine Bests Old School Antianginal Medications
Older medications show greater odds for revascularization, higher ER rates
Prediabetes Linked to Incident Cardiovascular Disease
In U.K. cohort, association varied with ethnicity and with prediabetes definition criterion
Fish Oil Supplementation Doesn’t Cut Inflammatory Markers
Supplementation with EPA+DHA doesn't reduce markers of inflammation in healthy adults
Displaying Prices to Providers Seems to Reduce Order Costs
Review shows price display decreases aggregate order costs more frequently than order volume
Competition for Fellowships Broke Records in 2015
One-quarter of applicants did not didn't receive a position
Prescribing Drugs ‘Off-Label’ Can Pose Serious Safety Risks
Study raises concerns about using meds to treat conditions for which they weren't approved
Increasing Numbers of Med School Applicants, Enrollees
Med school classes continuing to diversify, with increases in nearly every racial/ethnic category
Synchronized Prescription Renewal Process Saves Time
Renewing all patient's stable medications for 12 to 15 months can save time and money
Despite Progress, Mortality Still Risk Up in Patients With T2DM
Risks vary per age, glycemic control, and renal complications
